Search

Your search keyword '"R Edward, Coleman"' showing total 300 results

Search Constraints

Start Over You searched for: Author "R Edward, Coleman" Remove constraint Author: "R Edward, Coleman"
300 results on '"R Edward, Coleman"'

Search Results

Catalog

Books, media, physical & digital resources

9. Type 2 diabetes mellitus, brain atrophy, and cognitive decline

10. Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy

11. Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study

12. Impact of 18F-Fluoride PET in Patients with Known Prostate Cancer: Initial Results from the National Oncologic PET Registry

13. Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem Correlates

14. Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant?

15. Does the Preparation and Utilization of 99mTc-Sulfur Colloid Affect the Outcomes of Breast Lymphoscintigraphy?

16. Impact of Consolidation Radiation Therapy in Stage III-IV Diffuse Large B-cell Lymphoma With Negative Post-Chemotherapy Radiologic Imaging

17. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

18. Amyloid- assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study

19. Variable-time positron emission tomography leg protocol to equalize noise for positron emission tomography/computed tomography acquisitions

20. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation

21. Impact of Dedicated Brain PET on Intended Patient Management in Participants of the National Oncologic PET Registry

22. Combination of Converging Collimators for High-Sensitivity Brain SPECT

23. CT Metrics of Airway Disease and Emphysema in Severe COPD

24. Radiation Dosimetry, Pharmacokinetics, and Safety of Ultratrace™ Iobenguane I-131 in Patients with Malignant Pheochromocytoma/Paraganglioma or Metastatic Carcinoid

25. Increasing Uptake Time in FDG-PET: Standardized Uptake Values in Normal Tissues at 1 versus 3 h

26. 18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN CHILDREN AND ADOLESCENTS WITH TRAUMATIC BRAIN INJURY

27. Diagnosis and therapy of carcinoid tumors—current state of the art and future directions

28. Radioiodinated MIBG in paraganglioma and pheochromocytoma: previous results and early experiences using no-carrier-added MIBG

29. A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost

30. Quantitative Effects of Contrast Enhanced CT Attenuation Correction on PET SUV Measurements

31. Clinical Experience with α-Particle–Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

32. Left Ventricular Functional Assessment in Mice: Feasibility of High Spatial and Temporal Resolution ECG-gated Blood Pool SPECT

33. Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions

34. Head and Neck Cancer: Dedicated FDG PET/CT Protocol for Detection—Phantom and Initial Clinical Studies

35. 3′-Deoxy-3′-[F-18]Fluorothymidine Positron Emission Tomography in Patients with Recurrent Glioblastoma Multiforme: Comparison with Gd-DTPA Enhanced Magnetic Resonance Imaging

36. Changes in plasma volume associated with mental stress ischemia in patients with coronary artery disease

37. Salvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primary and Metastatic Malignant Brain Tumors: Phase II Study Results

38. Positron Emission Tomography Diagnosis of Alzheimer's Disease

39. Concurrent PET/CT with an Integrated Imaging System: Intersociety Dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance

40. Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: Case study

41. [18F]Fluorodeoxyglucose-Positron Emission Tomography in Patients with Medulloblastoma

42. Outcome Prediction in Patients at High Risk for Coronary Artery Disease: Comparison between99mTc Tetrofosmin and99mTc Sestamibi

43. Positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer

44. Regional Cardiac Sympathetic Innervation Early and Late After Transmyocardial Laser Revascularization

45. Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future

46. [Untitled]

47. Screening for Cerebral Metastases with FDG PET in Patients Undergoing Whole-Body Staging of Non–Central Nervous System Malignancy

49. Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography

50. Positron emission tomography imaging of brain tumors